MEK-inhibitor (inh) and hydroxychloroquine (HCQ) in <i>KRAS</i>-mutated advanced pancreatic ductal adenocarcinoma (PDAC).Maahum Mehdi, Mandana Kamgar, Gulrayz Ahmed et al.|Journal of Clinical Oncology|2022Cited by 7